It could be argued, however, that like many other cancer types the NF-κB pathway is constitutively over-activated in bladder cancer cells37, 38, thus representing a heightened activation state that may not reflect how NF-κB acts in normal urothelial cells. This evidence concerns the gene NFKB1 and urinary bladder carcinoma.